Eugia US LLC recalls Lidocaine HCl Injection
- Published
- 10 Jun 2026
- Units affected
- 168,300 vials
- Agency
- FDA
- Country
- United States
The hazard
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
- Brand / company
- Eugia US LLC
- Codes / lots
- Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
- Distribution
- US Nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 10 Jun 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.